Cell Medica collaborators at Baylor College of Medicine publish paper describing the development of CMD-502

September 4, 2019

4 Sep 2019: Published in Clinical Cancer Research (https://clincancerres.aacrjournals.org/content/early/2019/09/04/1078-0432.CCR-19-0421).

This paper by our academic collaborators at Baylor College of Medicine, summarizes the pre-clinical work they have undertaken to select the GD2 CAR-NKT clinical construct which is now in use in the ongoing GINAKIT2 study in patients with relapsed/refractory high-risk neuroblastoma.

Other News